Novartis AG Research and Development Expenses 2012-2026 | NVS
Novartis AG research and development expenses for the twelve months ending March 31, 2026 were $11.574B, a 16.12% increase year-over-year.
- Novartis AG annual research and development expenses for 2025 were $11.2B, a 11.75% increase from 2024.
- Novartis AG annual research and development expenses for 2024 were $10.022B, a 11.86% decline from 2023.
- Novartis AG annual research and development expenses for 2023 were $11.371B, a 23.98% increase from 2022.